arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Amphastar Pharmaceuticals, Inc.

AMPH
$20.75 ▲ +0.95 (+4.80%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
55 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
75
Health
Good
Neutral
auto_awesome

Analytical Summary

Amphastar Pharmaceuticals, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $940.4M
Dividend Yield
Revenue Growth 0.4%
Op. Margin 8.0%
ROIC None
FCF / Share $0.85
Trailing P/E 148.2x
Price / Book
FCF Yield 4.1%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

55-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$171.17M
— +0.4%
Net Income Profit after all expenses
$6.42M
↓ -74.6%
Operating Margin Operating profit as % of sales
8.0%
↓ -59.1% 74th
FCF / Share Free cash flow per share
$0.85
↑ +65.3%
Long-Term Debt Long-term obligations
$619.71M
↓ -5.1%

Health Breakdown

Profitability
74
Financial Health
76
Cash Quality
74

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 55 quarters